Rolando Satzke

Support healthcare organizations in expanding their operations into the rapidly growing emerging markets by offering strategies that address market challenges, with sustainable impact and business growth. Engage with South-South partnerships for market expansion, based on an extensive network of strategic partners in emerging markets, including governmental entities, non-governmental organizations, health institutions, and industry associations.

• Developed a Social Enterprise and an Inclusive business model for revenue generation and women empowerment.

• Licensing, manufacturing, and supply agreements for broader access to innovative therapies, fostering the South-South collaboration.

• Strategic advisory projects for Africa, including health systems and competitive evaluation for access strategies.

• Field Research in NTD endemic African regions, presenting strategies to support sustainable disease control programs.

Drove strategic business development and portfolio management initiatives, focusing on differentiated transactions to bolster both short and long-term value streams. Oversee in- and out-licensing deals in alignment with the company's mid- to long-ter m portfolio strategy. Execute a strategic roadmap, including re-engineer ing of organizational structures, stakeholder relationshi p establishment, commercial, tender strategy and pricing design, integrated supply chain management from API manufactur ing to EU release, comprehensive risk assessments, and ensuring GMP processes and regulatory compliance.

• Successfully led a ~10+ Mn USD acquisition deal, significantly expanding operational capabilities and market reach.

• Pioneered a 5-year strategic portfolio launch, positioning the company for a strong ROI in the German generics market.

• Re-engineer ed organizational structures to enhance efficiency and adaptability in a dynamic industry landscape.

Revamped the Novartis social business model in Africa, establishing streamlined reporting mechanisms that enhanced both socia l initiatives and commercial ventures. Drove financial sustainability by broadening distribution networks and extending patient access. Spearheaded the integration of all divisions under the One Novartis strategy, harmonizing social responsibilities with fiscal goals. Restored Novartis' leadership in the global antimalarial market, surpassing established business objectives. Developed comprehensive portfolio and access strategies through alliances with public entities and non-governmental organizations.

• Co-created and implemented the One Novartis strategy, achieving a unified approach to healthcare in Africa, steering the cross-divisional teams' collaboration.

• Successfully negotiated partnerships with NGOs and the Public Sector, resulting in enhanced access to essential medications for underserved populations.

• Oversaw the revitalization of antimalarial product lines, leading to a significant recovery in global market share.

• Developed and executed disruptive access and tender strategies, integrating portfolio management with pricing models responsive to the needs of diverse patient groups.